Blood Reviews
Volume 20, Issue 1 , Pages 51-60, January 2006

Thrombotic Thrombocytopenic Purpura: aetiology, pathophysiology and treatment

  • R.J.A. Murrin

      Affiliations

    • Department of Haematology, Sandwell General Hospital, Sandwell and West Birmingham Hospitals NHS Trust, West Midlands, UK
    • Corresponding Author InformationCorresponding author.
  • ,
  • J.A. Murray

      Affiliations

    • Department of Haematology, Selly Oak Hospital, University Hospital of Birmingham, NHS Foundation Trust, UK

published online 29 March 2005.

Summary 

Thrombotic thrombocytopenic purpura (TTP) is a rare disorder whose varied clinical manifestations result from the formation of platelet-rich thrombi within the microvasculature and consequent tissue ischaemia.

This review will outline how, in the eighty years since its initial description, scientific discoveries have not only led to a deeper understanding of the fundamental pathophysiology of TTP, but have also contributed to advances in the clinical management of this condition.

Current research in this field will hopefully provide the basis for the design and development of novel therapeutic strategies.

Keywords: Thrombotic thrombocytopenic purpura, Aetiology, Pathophysiology, Treatment, Review

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0268-960X(05)00019-6

doi:10.1016/j.blre.2005.02.001

Blood Reviews
Volume 20, Issue 1 , Pages 51-60, January 2006